Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?
- PMID: 363433
- DOI: 10.1007/BF00607443
Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?
Abstract
Because of the differing opinions on the value of glucagon and the best way of administering it in severe hypoglycaemia induced by sulphonylurea drugs, experiments were conducted on normal subjects, and in diabetic patients before and during treatment with chlorpropamide. In all subjects glucagon raised blood sugar concentrations, and produced a greater and more prolonged increase in blood glucose concentrations when given intramuscularly than when given intravenously. Hypoglycaemia did not occur in any subject.
Similar articles
-
Glucagon in sulphonylurea hypoglycaemia.Lancet. 1968 May 25;1(7552):1154. doi: 10.1016/s0140-6736(68)90218-3. Lancet. 1968. PMID: 4171871 No abstract available.
-
Glucagon in sulphonylurea hypoglycaemia?Lancet. 1968 Feb 10;1(7537):303-4. doi: 10.1016/s0140-6736(68)90157-8. Lancet. 1968. PMID: 4170758 No abstract available.
-
Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose.Prehosp Disaster Med. 1998 Apr-Dec;13(2-4):44-50. Prehosp Disaster Med. 1998. PMID: 10346406 Clinical Trial.
-
Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?Diabetes Obes Metab. 2018 Aug;20(8):1812-1816. doi: 10.1111/dom.13317. Epub 2018 May 2. Diabetes Obes Metab. 2018. PMID: 29652110 Review.
-
Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.Crit Care. 2005;9(6):543-9. doi: 10.1186/cc3807. Epub 2005 Sep 7. Crit Care. 2005. PMID: 16356235 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources